News

Legal Action Looms: XPEL Investors Urged to Act Before Deadline

Legal Action Looms: XPEL Investors Urged to Act Before Deadline

Important Update for XPEL Investors

In a recent announcement, Glancy Prongay & Murray LLP has highlighted a pressing deadline that XPEL investors need to be aware of. If you have invested in XPEL, Inc. (NASDAQ: XPEL), it is crucial to note the upcoming deadline for filing a lead plaintiff motion in an ongoing class action. This motion must be submitted by October 7, 2024.

Understanding the Class Action Lawsuit

This class action lawsuit has been initiated on behalf of investors who purchased or acquired securities of XPEL between November 8, 2023, and May 2, 2024. This period is referred to as the 'Class Period' within legal documents. If you find yourself among those who incurred losses during this timeframe, it may be beneficial to consider your options for recovery under the federal securities laws.

How to Participate in the Class Action

If you believe you are eligible and wish to take part in this legal action, you are encouraged to submit your contact information to discuss the possibility of recovering losses. You can reach out to Charles H. Linehan from GPM at 310-201-9150 or toll-free at 888-773-9224 for further information.

XPEL's Recent Financial Performance

XPEL recently released its financial results for the first quarter of 2024, revealing a mere 5% growth in revenue compared to the previous year. More concerning was the revelation that the company has been losing customers in the aftermarket sector, which raised alarm bells among investors.

Following this announcement, the market reacted sharply; XPEL's stock plummeted by $20.93, a staggering 38.9% decline, leaving shares closing at $32.86 on the same day. This drop indicates significant concerns surrounding the company's financial health and market competitiveness.

What the Class Action Allegations Entail

The core of the complaint from the class action alleges that during the Class Period, the defendants of XPEL made materially false or misleading statements. They also failed to disclose serious adverse facts affecting the company’s business and operational outlook. Among the significant issues highlighted are:

  • Competitors were capturing an increasing share of the market, impacting XPEL's customer base.
  • The company’s revenue growth increasingly relied on its existing clients and partners, raising concerns about sustainability.
  • Projected revenue growth for 2023 and 2024 is expected to decline.
  • Positive public statements by company executives lacked a reasonable basis and misled investors.

How Does This Impact You?

This class action serves as a reminder for all investors who acquired XPEL shares to be vigilant about their investments. Even if you choose to remain an absent member of the class, staying informed is crucial. Remember, you have the option to retain legal counsel to explore your rights regarding this matter.

Stay Updated

For those interested in ongoing updates about this situation, XPEL encourages following them on various social media platforms like LinkedIn and Twitter. Engaging with these channels can help keep you informed about critical developments as they arise.

Frequently Asked Questions

1. What is the deadline for filing a lead plaintiff motion?

The deadline for filing a lead plaintiff motion in the class action lawsuit against XPEL is October 7, 2024.

2. How can I participate in the class action lawsuit?

Eligible investors can submit their contact information to discuss participation and potential recovery options with GPM.

3. What prompted the class action lawsuit?

The lawsuit was prompted by allegations of misleading statements and undisclosed adverse facts regarding XPEL's financial performance.

4. What are the implications of XPEL's recent stock decline?

The substantial decline in stock price reflects market concerns about XPEL's customer retention and overall financial health.

5. Who can I contact for more information?

You can contact Charles H. Linehan at Glancy Prongay & Murray LLP for additional information on your rights and potential claims.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 0

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 3

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 2

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading

Top 5 Most Recently Viewed Articles

Cenovus Energy Expands Portfolio with Major Share Acquisition

Updated Category News Views 184

Cenovus Energy Acquires Significant Stake in MEG Energy Cenovus Energy Inc. (TSX: CVE) has recently made a strategic move to acquire 21,723,540 common shares of MEG Energy Corp. ("MEG"), amounting to 8.5% of the total shares outstanding. This acquisition positions Cenovus as a notable shareholder in MEG, reflecting the company’s commitment to growth within the energy...

Continue Reading
Arthur J. Gallagher & Co. Prepares for Q4 2024 Earnings Report

Updated Category News Views 288

Arthur J. Gallagher & Co. Prepares for Q4 2024 Earnings Release Arthur J. Gallagher & Co. (NYSE: AJG) is set to announce its fourth quarter 2024 earnings following the market close on the last day of January 2025. This eagerly awaited financial update will provide insights into the company's performance and strategic direction as it continues to thrive in the dynamic...

Continue Reading
KKR Enhances Tender Offer Strategy for FUJI SOFT Shares

Updated Category News Views 72

KKR Revamps Tender Offer Strategy for FUJI SOFT Shares KKR, a leading global investment firm, has recently made an important change to its tender offer for FUJI SOFT INCORPORATED's common shares. This strategic update appears to provide shareholders with new options and greater flexibility in the tendering process. Decoding the Amendment Statement Alongside the tender...

Continue Reading
TC Transcontinental Sells Industrial Packaging Division

Updated Category News Views 178

TC Transcontinental Makes Strategic Move in Packaging Sector TC Transcontinental has announced an important step in its growth strategy by selling its industrial packaging operations to Hood Packaging Corporation. This significant transaction is valued at US$95 million, which translates to approximately C$132 million, subject to adjustments related to working capital....

Continue Reading
Investing in Wingstop: A Journey Over the Last Five Years

Updated Category News Views 116

Investing in Wingstop: A Journey Over the Last Five Years Wingstop (NASDAQ: WING) has demonstrated impressive growth over the past five years, exceeding market expectations with an annualized return of 34.38%. The company now boasts a market capitalization of $11.69 billion, highlighting its strong performance in the fast-casual dining sector. Your Investment in WING:...

Continue Reading